Recently, the American Association of Pharmaceutical Scientists (AAPS) released a post on their blog authored by Binodh DeSilva, Executive Director of Immunochemistry and Biomarker Development and Mark E. Arnold, Ph.D., Executive Director of the Bioanalytical Sciences and Selective Integration Department at Bristol Myer Squibb on the FDA and industry discussing crucial draft bioanalytical method validation guidance. Here is an excerpt from the post:
Crystal City V – FDA and Industry Discuss Crucial Draft Bioanalytical Method Validation Guidance
[fa icon="calendar'] Dec 6, 2013 9:00:00 AM / by Admin posted in AAPS, American Association of Pharmaceutical Scientists, Bioanalytical Method Validation, biotechnology, Blog, contract research organizations, Pharmaceutical, pharmaceutical